CD69 expression on CD4- T lymphocytes after in vitro stimulation with tuberculin is an indicator of immune sensitization against Mycobacterium tuberculosis antigens

Clinical and Diagnostic Laboratory Immunology

Volumn 12, Issue 1, 2005, Pages 101-106

  Avgustin, Bojana ^b   Kotnik, Vladimir ^a   Škoberne, Mojca ^a   Malovrh, Tadej ^a   Skralovnik Stern, Aleksandra ^b   Terčelj, Marjeta ^b  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CD69 ANTIGEN; GAMMA INTERFERON; MYCOBACTERIUM ANTIGEN; TUBERCULIN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BCG VACCINATION; BLAST TRANSFORMATION; CHEMOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SENSITIZATION; SKIN INDURATION; T LYMPHOCYTE; TUBERCULIN TEST; TUBERCULOSIS;

ADULT; AGED; ANTIGENS, BACTERIAL; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; BCG VACCINE; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; TUBERCULIN; TUBERCULOSIS;

EID: 12544258973     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.12.1.101-106.2005     Document Type: Article

References (39)

1. Advisory Council on the Elimination of Tuberculosis. 1999. Tuberculosis elimination revisited: obstacles, opportunities, and a renewed commitment. Morb. Mortal. Wkly. Rep. 48:1-13.
2. American Thoracic Society, American Lung Association, Center for Disease Control and Prevention. 2000. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am. J. Respir. Crit. Care Med. 161:5221-5247.
3. American Thoracic Society, American Lung Association, and Centers for Disease Control and Prevention. 2000. Diagnostic standards and classification of tuberculosis in adults and children. Am. J. Respir. Crit. Care Med. 161:1376-1395.
4. Andersen, P., A. B. Andersen, A. L. Sorensen, and S. Nagai. 1995. Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice. J. Immunol. 154:3359-3372.
5. Andersen, P., D. Askgaard, L. Ljungqvist, M. W. Bentzon, and I. Heron. 1991. T-cell proliferative response to antigens secreted by Mycobacterium tuberculosis. Infect. Immun. 59:1558-1563.
6. Antas, P. R., E. B. Oliveira, A. S. Milagres, K. C. Franken, T. H. Ottenhoff, P. Klatser, E. N. Sarno, and E. P, Sampaio. 2002. Kinetics of T cell-activation molecules in response to Mycobacterium tuberculosis antigens. Mem. Inst. Oswaldo Cruz 97:1097-1099.
7. Barnes, P. F., J. S. Abrams, S. Lu, P. A. Sieling, T. H. Rea, and R. L. Modlin. 1993. Patterns of cytokine production by mycobacterium-reactive human T-cell clones. Infect. Immun. 61:197-203.
8. Bhattacharyya, S., R. Singla, and A. B. Dey. 1999. Dichotomy of cytokine profiles in patients and high-risk healthy subjects exposed to tuberculosis. Infect. Immun. 67:5597-5603.
9. Brock, I., M. E. Munk, A. Kok-Jensen, and P. Andersen. 2001. Performance of whole blood IFN-gamma test for tuberculosis diagnosis based on PPD or the specific antigens ESAT-6 and CFP-10. Int. J. Tuberc. Lung Dis. 5:462-467.
10. Converse, P. J., S. L. Jones, J. Astemborski, D. Vlahov, and N. M. Graham. 1997. Comparison of a tuberculin interferon-gamma assay with the tuberculin skin test in high-risk adults: effect of human immunodeficiency virus infection. J. Infect. Dis. 176:144-150.
11. Daniel, T. 1980. The immunology of tuberculosis. Clin. Chest Med. 1:189-201.
12. Desem, N., and S. L. Jones. 1998. Development of a human gamma interferon enzyme immunoassay and comparison with tuberculin skin testing for detection of Mycobacterium tuberculosis infection. Clin. Diagn. Lab. Immunol. 5:531-536.
13. Hara, T., L. K. Jung, J. M. Bjorndahl, and S. M. Fu. 1988. Human T cell activation. III. Rapid induction of a phosphorylated 28 kD/32 kD disulfide-linked early activation antigen (EA 1) by 12-o-tetradecanoyl phorbol-13-acetate, mitogens, and antigens. J. Exp. Med. 164:1988-2005.
14. Howard, A. D., and B. S. Zwilling. 1999. Reactivation of tuberculosis is associated with a shift from type 1 to type 2 cytokines. Clin. Exp. Immunol. 115:428-434.
15. Hsieh, S. M., C. C. Hung, S. C. Pan, J. T. Wang, H. C. Tsai, M. Y. Chen, and S. C. Chang. 2000. Restoration of cellular immunity against tuberculosis in patients coinfected with HIV-1 and tuberculosis with effective antiretroviral therapy: assessment by determination of CD69 expression on T cells after tuberculin stimulation. J. Acquir. Immune Defic. Syndr. 25:212-220.
16. Huebner, R. E., M. F. Schein, and J. B. Bass. 1993. The tuberculin skin test. Clin. Infect. Dis. 17:968-975.
17. Johnson, P. D., and R. L. Stuart. 1999. Tuberculin-purified protein derivative-, MPT-64-, and ESAT-6-stimulated gamma interferon responses in medical students before and after Mycobacterium bovis BCG vaccination and in patients with tuberculosis. Clin. Diagn. Lab. Immunol. 6:934-937.
18. Krowka, J. F., B. Cuevas, D. C. Maron, K. S. Steimer, M. S. Ascher, and H. W. Sheppard. 1996. Expression of CD69 after in vitro stimulation: a rapid method for quantitating impaired lymphocyte responses in HIV-infected individuals. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 11:95-104.
19. Mazurek, G. H., and M. E. Villarino, and Centers for Disease Control and Prevention. 2003. Guidelines for using the QuantiFERON-TB test for diagnosing latent Mycobacterium tuberculosis infection. Morb. Mortal. Wkly. Rep. Recomm. Rep. 52:15-18.
20. Mazurek, G. H., P. A. LoBue, C. L. Daley, J. Bernardo, A. A. Lardizabal, W. R. Bishai, M. F. Iademarco, and J. S. Rothel. 2001. Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection. JAMA 286:1740-1747.
21. + T lymphocytes by flow cytometry. J. Immunol. Methods 208:49-59.
22. Menzies, D. 1999. Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion. Am. J. Respir. Crit. Care Med. 159:15-21.
23. Mukherjee, S., R. Lumb, P. Robinson, and R. Stapledon. 1995. Evaluation of gamma interferon assay in human mycobacterial infection. Aust. N. Z. J. Med. 25:436.
24. Orme, I. M., P. Andersen, and W. H. Boom. 1993. T cell response to Mycobacterium tuberculosis. J. Infect. Dis. 167:1481-1497.
25. Perfetto, S. P., T. E. Hickey, P. J. Blair, V. C. Maino, K. F. Wagner, S. Zhou, D. L. Mayers, D. St. Louis, C. H. June, and J. N. Siegel. 1997. Measurement of CD69 induction in the assessment of immune function in asymptomatic HIV-infected individuals. Cytometry 30:1-9.
26. Portales-Perez, D. P., L. Baranda, E. Layseca, N. A. Fierro, H. de la Fuente, Y. Rosenstein, and R. Gonzalez-Amaro. 2002. Comparative and prospective study of different immune parameters in healthy subjects at risk for tuberculosis and in tuberculosis patients. Clin. Diagn. Lab. Immunol. 9:299-307.
27. Pottumarthy, S., A. J. Morris, A. C. Harrison, and V. C. Wells. 1999. Evaluation of the tuberculin gamma interferon assay: potential to replace the Mantoux skin test. J. Clin. Microbiol. 37:3229-3232.
28. Sanchez, F. O., J. I. Rodriguez, G. Agudelo, and L. F. Garcia. 1994. Immune responsiveness and lymphokine production in patients with tuberculosis and healthy controls. Infect. Immun. 62:5673-5678.
29. Sepkowitz, K. A. 1996. Tuberculin skin testing and the health care worker: lessons of the Prophit Survey. Tuber. Lung Dis. 77:81-85.
30. Skoberne, M., T. Malovrh, A. Skralovnik-Stern, and V. Kotnik. 2000. Human peripheral blood lymphocytes sensitised to PPD respond to in vitro stimulation with increased expression of CD69 and CD134 activation antigens and production of Th-1 type cytokines. Pflugers Arch. 440:58-60.
31. Sodhi, A., J. Gong, C. Silva, D. Qian, and P. F. Barnes. 1997. Clinical correlates of interferon gamma production in patients with tuberculosis. Clin. Infect. Dis. 25:617-620.
32. Song, C. H., H. J. Kim, J. K. Park, J. H. Lim, U. O. Kim, J. S. Kim, T. H. Paik, K. J. Kim, J. W. Suhr, and E. K. Jo. 2000. Depressed interleukin-12 (IL-12), but not IL-18, production in response to a 30- or 32-kilodalton mycobacterial antigen in patients with active pulmonary tuberculosis. Infect. Immun. 68:4477-4484.
33. Streeton, J. A., N. Desem, and S. L. Jones. 1998. Sensitivity and specificity of a gamma interferon blood test for tuberculosis infection. Int. J. Tuberc. Lung Dis. 2:443-450.
34. Surcel, H. M., M. Troye-Blomberg, S. Paulie, G. Andersson, C. Moreno, G. Pasvol, and J. Ivanyi. 1994. Th1/Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens. Immunology 81:171-176.
35. Talreja, J., A. Bhatnagar, S. K. Jindal, and N. K. Ganguly. 2003. Influence of Mycobacterium tuberculosis on differential activation of helper T-cells. Clin. Exp. Immunol. 131:292-298.
36. Testi, R., D. D'Ambrosio, R. De Maria, and A. Santoni. 1994. The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cells. Immunol. Today 15:479-483.
37. Torres, M., T. Herrera, H. Villareal, E. A. Rich, and E. Sada. 1998. Cytokine profiles for peripheral blood lymphocytes from patients with active pulmonary tuberculosis and healthy household contacts in response to the 30-kilodalton antigen of Mycobacterium tuberculosis. Infect. Immun. 66:176-180.
38. Zhang, M., Y. Lin, D. V. Iyer, J. Gong, J. S. Abrams, and P. F. Barnes. 1995. T-cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect. Immun. 63:3231-3234.
39. Ziegler, S. F., F. Ramsdell, and M. R. Alderson. 1994. The activation antigen CD69. Stem Cells 12:456-465.